Siena, Italy

J Russell Thomas

This inventor holds 1 USPTO granted patent. Top assignee: Siena Biotech S.p.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Russell Thomas. Retrieved from https://idiyas.com/inventor/j-russell-thomas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Russell Thomas: Innovator in Hedgehog Pathway Therapeutics

Introduction

J Russell Thomas is a notable inventor based in Siena, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of the hedgehog signaling pathway. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

J Russell Thomas holds a patent titled "Hedgehog pathway antagonists and therapeutic applications thereof." This patent focuses on heterocyclic compounds that modulate the hedgehog signaling pathway, along with the pharmaceutical compositions and their therapeutic applications. He has 1 patent to his name, reflecting his expertise and commitment to innovation in this area.

Career Highlights

Currently, J Russell Thomas is associated with Siena Biotech S.p.a., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical science.

Collaborations

Throughout his career, J Russell Thomas has worked alongside esteemed colleagues such as Galla Pericot Mohr and Chiara Caramelli. These collaborations have fostered a dynamic environment for innovation and have led to advancements in their shared research interests.

Conclusion

J Russell Thomas exemplifies the spirit of innovation in the pharmaceutical industry through his work on hedgehog pathway antagonists. His contributions not only highlight his expertise but also pave the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…